DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ advanced 2.09% to $7.32 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.26% to 19,075.26 and the Dow Jones Industrial Average falling 0.43% to 43,433.12.
The stock's rise snapped a two-day losing streak.
Novavax Inc. closed 69.32% below its 52-week high of $23.86, which the company achieved on June 6th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.81% to $163.08, Pfizer Inc. $(PFE)$ fell 1.20% to $26.42, and Merck & Co. Inc. $(MRK)$ fell 2.24% to $89.38.
Trading volume (3.9 M) remained 225,807 below its 50-day average volume of 4.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 26, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 26, 2025 17:31 ET (22:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。